What Is Coolsculpting Treatment?
Accern also assigned news headlines about the medical equipment provider an impact score of 45.5159739029091 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future. Separately, Aegis reissued a “hold” rating and set a $56.00 price objective on shares of Zeltiq Aesthetics in a report on Monday, April 24th. Eight equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Zeltiq Aesthetics currently has an average... Read more